Estimates and projections of value of life lost from cancer deaths in the United States

Journal of the National Cancer Institute

Volumn 100, Issue 24, 2008, Pages 1755-1762

  Yabroff, K Robin ^a   Bradley, Cathy J ^b   Mariotto, Angela B ^a   Brown, Martin L ^a   Feuer, Eric J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER CONTROL; CANCER MORTALITY; COLORECTAL CANCER; LIFE EXPECTANCY; LUNG CANCER; PRIORITY JOURNAL; PROSTATE CANCER; SENSITIVITY ANALYSIS; SEX DIFFERENCE; SOCIOECONOMICS; TUMOR LOCALIZATION; UNITED STATES;

ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; FORECASTING; HUMANS; LIFE TABLES; LUNG NEOPLASMS; MALE; MIDDLE AGED; MORTALITY; NEOPLASMS; PROSTATIC NEOPLASMS; SEX DISTRIBUTION; SEX FACTORS; UNITED STATES; VALUE OF LIFE;

EID: 58049202257     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djn383     Document Type: Article

References (25)

1. Brown ML, Lipscomb J, Snyder C. The burden of illness in cancer: economic cost and quality of life. Ann Rev Public Health. 2001;22:91-113.
2. Brown ML, Yabroff KR. Economic impact of cancer in the United States. In: David Schottenfeld, Joseph F Faumeni J, eds. Cancer Epidemiology and Prevention. New York, NY: Oxford University Press; 2006:202-214.
3. Nordhaus WD. The health of nations: the contribution of improved health to living standards. In: Murphy K, Topel R, eds. Measuring the Gains From Medical Research: An Economic Approach. Chicago, IL: University of Chicago Press; 2003:9-40.
4. Brown ML, Hodgson TA, Rice DP. Economic impact of cancer in United States. In: Schottenfeld D, Faumeni JF Jr, eds. Cancer Epidemiology and Prevention. New York, NY: Oxford University Press; 1996:255-266.
5. Rice DP, Hodgson TA. Social and Economic Implications of Cancer in the United States. DHHS Publication No. PHS81-1404. Washington, DC: US Government Printing Office;1981. Vital and Health Statistics, Series 3, No. 20.
6. Max W, Rice DP, Sung H-Y, Michel M, Breuer W, Zhang X. The economic burden of prostate cancer, California, 1998. Cancer. 2002;94(11):2906- 2913.
7. Max W, Rice DP, Sung H-Y, Michel M, Breuer W, Zhang X. The economic burden of gynecologic cancers in California. Gynecol Oncol. 1998 2003;88(2):96-103.
8. Cutler DM, Gruber J, Hartman RS, Landrum MB, Newhouse JP, Rosenthal MB. The Economic Impacts of the Tobacco Settlement. 2008; NBER Working Paper No. W7760. http://ssrn.com/abstract=235716. Accessed October 9, 2008.
9. Lichtenberg FR. Sources of U.S. Longevity Increase, 1960-1997 (December 2000). 2008. CESifo Working Paper Series No. 405. http://ssrn.com/abstract=263113. Accessed October 9, 2008.
10. Ries LAG, Harkins D, Krapcho M, et al. SEER Cancer Statistic Review, 1975-2003. Bethesda, MD: National Cancer Institute; 2006.
11. Humphrey LL, Helfand M, Chan BK, Woolf SH. Breast cancer screening: a summary of evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137(5 Part 1):347-360.
12. Pignone M, Rich M, Teutsch SM, Berg AO, Lohr KN. Screening for colorectal cancer in adults at average risk: a summary of the evidence for the US Preventive Services Task Force. Ann Intern Med. 2002;137(2):132-141.
13. Centers for Disease Control and Prevention. Cigarette smoking - attributable mortality and years of potential life lost - United States, 1990. MMWR Morb Mortal Wkly Rep. 1993;42(33):645-649.
14. Millikan R, Logothetis C. Update of the NCCN guidelines for treatment of prostate cancer. Oncology. 1997;11(11A):180-193.
15. U.S. Preventive Services Task Force. Guide to Clinical Preventive Services: Report of the US Preventive Services Task Force. 2nd ed. Baltimore, MD: Williams & Wilkins; 1996.
16. Breen N, Wagener DK, Brown ML, Davis WW, Ballard-Barbash R. Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 national health interview surveys. J Natl Cancer Inst. 2001;93(22):1704-1713.
17. Harlan LC, Clegg LX, Abrams J, Stevens JL, Ballard-Barbash R. Community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987-2000. J Clin Oncol. 2006;24(6):872-877.
18. World Health Organization Commission on Macroeconomics and Health. Macroeconomics and Health: Investing in Health for Economic Development. Geneva: World Health Organization; 2001.
19. US Department of Labor Bureau of Labor Statistics, Office of Productivity and Technology. Comparative Real Gross Domestic Product Per Capita and Per Employed Person. Sixteen Countries 1960-2006. 2008. http://www.bls.gov/fls/ flsgdp.pdf. Accessed October 9, 2008.
20. Hirth RA, Chernew ME, Miller E, Fendrick M, Weissert WG. Willingness to pay for a quality-adjusted life year: in search of a standard. Med Decis Making. 2000;20(3):332-342.
21. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-Effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996.
22. National Cancer Institute. Cancer Intervention and Surveillance Modeling Network (CISNET). http://cisnet cancer gov/index html 2007. Accessed December 20, 2007.
23. Bradley CJ, Yabroff KR, Dahman B, Feuer E, Mariotto A, Brown ML. Productivity costs of cancer mortality in the United States, 2000 to 2020. J Natl Cancer Inst. 2008;100(24):1763-1770.
24. Yabroff KR, Mariotto AB, Feuer E, Brown ML. Projections of the costs associated with colorectal cancer care in the United States, 2000-2020. Health Econ. 2008;17(8):947-959.
25. Percy C, Stanek E, Gloeckler L. Accuracy of cancer death certificates and its effect on cancer mortality statistics. Am J Public Health. 1981;71(3):242-250.